Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05641675

Non-invasive Pulmonary Artery Prediction (ADOPTS)

Conditions: Heart Failure, Pulmonary Arterial Hypertension

Sex: All
Ages: 20 Years – N/A
Enrollment: 25
Sponsor: Silverleaf Medical Sciences INC

Location: United States

Summary

A proprietary machine-learning algorithm has been developed to model continuous pulmonary artery pressure (PAP), a physiologic marker of cardiopulmonary function. The algorithm was developed from PAP recordings obtained during invasive right heart catheterization. The study will evaluate whether this algorithm can perform as well when embedded into a non-invasive wearable device that records EKG, heart sounds, and thoracic impedance has yet to be established.

Eligibility Criteria

Inclusion Criteria:Written informed consent and authorization to use and disclose health information.20 years of age or older.Diagnosis of HF for >3 months, with preserved or reduced left ventricular ejection fraction (LVEF).Female subjects of childbearing age with a negative urine or serum pregnancy test at the time of the right heart cauterization procedure and trial.Exclusion Criteria:Active infection.Unable to tolerate a right heart catheterization (RHC), in the investigator's opinion.Implantation of cardiac resynchronization therapy (CRT)<3 months before enrollment.Enrolled in concurrent studies that may confound the results of this study.Clinical condition that would not allow them to complete the study, in the investigator's opinion.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05641675). StuddyBuddy aggregates publicly available trial information.